CJC-1295 and Ipamorelin are usually studied together, but they act through two different mechanisms within the same growth-hormone axis — which is exactly why the pairing is of interest.
Two different roles
CJC-1295 (No-DAC) is a GHRH analog — it mimics growth-hormone-releasing hormone. Ipamorelin is a selective growth-hormone secretagogue that acts on a separate receptor pathway. One imitates the releasing signal; the other stimulates release through a complementary route.
Why the pair is studied
Researchers examine how a GHRH analog and a secretagogue together influence pulsatile growth-factor signaling — an example of a research blend where two mechanisms converge. See the combined mechanism of action and research overview.
Product page: CJC-1295 + Ipamorelin research vials.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.